Find en forsker – Københavns Universitet

Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. / Iversen, P; Madsen, P O; Corle, D K.

In: Scandinavian Journal of Urology and Nephrology. Supplement, Vol. 172, 1995, p. 65-72.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Iversen, P, Madsen, PO & Corle, DK 1995, 'Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study' Scandinavian Journal of Urology and Nephrology. Supplement, vol. 172, pp. 65-72.

APA

Iversen, P., Madsen, P. O., & Corle, D. K. (1995). Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. Scandinavian Journal of Urology and Nephrology. Supplement, 172, 65-72.

Vancouver

Iversen P, Madsen PO, Corle DK. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. Scandinavian Journal of Urology and Nephrology. Supplement. 1995;172:65-72.

Author

Iversen, P ; Madsen, P O ; Corle, D K. / Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. In: Scandinavian Journal of Urology and Nephrology. Supplement. 1995 ; Vol. 172. pp. 65-72.

Bibtex

@article{a9098d26bf9e40f1b719ce50e03d14c2,
title = "Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study",
abstract = "In a study by the Veterans Administration Cooperative Urological Research Group (VACURG), 142 patients with localized prostate cancer, VACURG stage I and II, were randomized between radical prostatectomy plus placebo versus placebo alone as initial treatment. 111 patients were evaluable for treatment comparison. Median follow-up for survival is 23 years. The prognostic value of Gleason histologic grading was confirmed. A difference in overall survival in favor of radical prostatectomy was observed in stage I patients. However, after adjustment for imbalance in age distribution, no statistically significant differences in survival could be demonstrated in either stage or in both stages combined. The results are discussed considering the small sample size and the limited statistical power of the study.",
author = "P Iversen and Madsen, {P O} and Corle, {D K}",
year = "1995",
language = "English",
volume = "172",
pages = "65--72",
journal = "Scandinavian Journal of Urology and Nephrology. Supplement",
issn = "0300-8886",
publisher = "Taylor & Francis",

}

RIS

TY - JOUR

T1 - Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study

AU - Iversen, P

AU - Madsen, P O

AU - Corle, D K

PY - 1995

Y1 - 1995

N2 - In a study by the Veterans Administration Cooperative Urological Research Group (VACURG), 142 patients with localized prostate cancer, VACURG stage I and II, were randomized between radical prostatectomy plus placebo versus placebo alone as initial treatment. 111 patients were evaluable for treatment comparison. Median follow-up for survival is 23 years. The prognostic value of Gleason histologic grading was confirmed. A difference in overall survival in favor of radical prostatectomy was observed in stage I patients. However, after adjustment for imbalance in age distribution, no statistically significant differences in survival could be demonstrated in either stage or in both stages combined. The results are discussed considering the small sample size and the limited statistical power of the study.

AB - In a study by the Veterans Administration Cooperative Urological Research Group (VACURG), 142 patients with localized prostate cancer, VACURG stage I and II, were randomized between radical prostatectomy plus placebo versus placebo alone as initial treatment. 111 patients were evaluable for treatment comparison. Median follow-up for survival is 23 years. The prognostic value of Gleason histologic grading was confirmed. A difference in overall survival in favor of radical prostatectomy was observed in stage I patients. However, after adjustment for imbalance in age distribution, no statistically significant differences in survival could be demonstrated in either stage or in both stages combined. The results are discussed considering the small sample size and the limited statistical power of the study.

M3 - Journal article

VL - 172

SP - 65

EP - 72

JO - Scandinavian Journal of Urology and Nephrology. Supplement

T2 - Scandinavian Journal of Urology and Nephrology. Supplement

JF - Scandinavian Journal of Urology and Nephrology. Supplement

SN - 0300-8886

ER -

ID: 48470687